国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
11期
33-35
,共3页
邵发保%周善存%张煜%王少波
邵髮保%週善存%張煜%王少波
소발보%주선존%장욱%왕소파
赖脯胰岛素%甘精胰岛素%2型糖尿病
賴脯胰島素%甘精胰島素%2型糖尿病
뢰포이도소%감정이도소%2형당뇨병
Iinsulin lispro%Insulin glarginc%Type 2 diabetes
目的 比较赖脯胰岛素联合甘精胰岛素与胰岛素泵在2型糖尿病强化治疗中的疗效和安全性.方法 将2型糖尿病病人随机分成两组,A组的病人采用三餐前赖脯胰岛素联合甘精胰岛素治疗,B组的病人采用胰岛素泵(使用赖脯胰岛素)降糖治疗.监测两组病人治疗前后全天血糖谱的变化,观察并比较血糖达标所需要的时间、胰岛素用量、低血糖发生率等情况.结果 A组与B组相比,在血糖达标所需的时间、胰岛素用量及低血糖发生率等方面没有显著性差异(P>0.05).结论 赖脯胰岛素联合甘精胰岛素治疗2型糖尿病患者,在疗效、安全性方面接近胰岛素泵,在治疗费用方面则具有一定的优势.
目的 比較賴脯胰島素聯閤甘精胰島素與胰島素泵在2型糖尿病彊化治療中的療效和安全性.方法 將2型糖尿病病人隨機分成兩組,A組的病人採用三餐前賴脯胰島素聯閤甘精胰島素治療,B組的病人採用胰島素泵(使用賴脯胰島素)降糖治療.鑑測兩組病人治療前後全天血糖譜的變化,觀察併比較血糖達標所需要的時間、胰島素用量、低血糖髮生率等情況.結果 A組與B組相比,在血糖達標所需的時間、胰島素用量及低血糖髮生率等方麵沒有顯著性差異(P>0.05).結論 賴脯胰島素聯閤甘精胰島素治療2型糖尿病患者,在療效、安全性方麵接近胰島素泵,在治療費用方麵則具有一定的優勢.
목적 비교뢰포이도소연합감정이도소여이도소빙재2형당뇨병강화치료중적료효화안전성.방법 장2형당뇨병병인수궤분성량조,A조적병인채용삼찬전뢰포이도소연합감정이도소치료,B조적병인채용이도소빙(사용뢰포이도소)강당치료.감측량조병인치료전후전천혈당보적변화,관찰병비교혈당체표소수요적시간、이도소용량、저혈당발생솔등정황.결과 A조여B조상비,재혈당체표소수적시간、이도소용량급저혈당발생솔등방면몰유현저성차이(P>0.05).결론 뢰포이도소연합감정이도소치료2형당뇨병환자,재료효、안전성방면접근이도소빙,재치료비용방면칙구유일정적우세.
Objective Comparing efficacy and safety between insulin lispro combined with insulin glargine and insulin pump in the intensified therapy of patients with type 2 diabetes. Methods The patients with type 2 diabetic were randomly divided into two groups. The patients in group A were given insulin lispro combined with insulin glargine before meals, and the patients in group B received insulin pump therapy by infusing insulin lispro. The changes of blood glucose spectrum in two groups were monitored before and after treatment the whole day, and the time and the insulin dosage of glucose up to grade, incidence of hypoglycemia and so on in two groups were observed and compared. Results There were no significant differences in the time and the insulin dosage of glucose up to grade, the incidence of hypoglycemia and so on between two groups (P>0.05). Conclusion The curative effect and safety of insulin lispro combined with insulin glargine on patients with type 2 diabetes were close to those of insulin pump, while has a certain advantage in treatment costs.